带有负抗体的优甲状腺格雷夫斯眼科医疗 (EGONA):基于病例的综合性审查
Maram Bonny1, Mariam Wehbe1, Rayan Zaydan1
1Medicine, University of Sharjah, Sharjah, ARE.
Cureus
|January 28, 2026
概括
带有负抗体 (EGONA) 的EuthyroidGraves'眼病症呈现独特,模仿经典的甲状腺眼病,尽管甲状腺水平正常. 诊断依赖于临床症状和成像,根据后来的甲状腺变化,预后会有所不同.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 内部医学 内部医学
背景情况:
- 带有负抗体 (EGONA) 的Euthyroid Graves眼病是一种罕见的疾病.
- 它与古典的格雷夫斯眼病类似,尽管甲状腺激素水平正常.
- 据信,潜在的发病因子与格雷夫斯眼科病的病因相同.
研究的目的:
- 审查和描述EGONA的各种临床表现.
- 为了突出EGONA的诊断方法.
- 总结EGONA的管理策略和结果.
主要方法:
- 在PubMed,PubMed Central和ScienceDirect上进行了系统的文献搜索.
- 纳入标准集中在英语病例报告中,EGONA在呈现时具有阴性甲状腺抗体.
- 数据提取涵盖了九篇文章中的12个案例的呈现,管理和结果.
主要成果:
- EGONA诊断依赖于临床检查和眼部成像.
- 治疗方法包括皮质类固醇,抗甲状腺药物和手术干预.
- 预后是可变的,受到甲状腺功能障碍或抗体阳性的后续发展的影响.
结论:
- EGONA代表了甲状腺眼病的一个独特的子集,需要具体的诊断考虑.
- 临床评估和成像对于在无甲状腺患者中诊断EGONA至关重要.
- EGONA的管理和预后受甲状腺状况的变化和抗体存在的影响.
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...


